Latin America Tumor Ablation Market Report and Forecast 2025-2034

Latin America Tumor Ablation Market Outlook

The global tumor ablation market size was valued at USD 1.9 billion in 2024, with Latin America holding a significant market share. The market is driven by the rising introduction of advanced technologies in tumor ablation. It is expected to grow at a CAGR of 14.2% during the forecast period of 2025-2034, with the values likely to attain USD 6.3 billion by 2034.

Key Takeaways

• Recent data reveals that 9 in 10 of the most populous nations in Latin America will observe at least a 64% increase in cancer patients by 2040 . The high cancer incidence is expected to directly impact market demand for this minimally invasive technique.

• One of the major Latin America tumor ablation market trends is the increased initiatives by both public and private organizations to spread awareness about cancer treatment strategies. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region.

• The market is also influenced by the minimally invasive nature of tumor ablation therapy which fuels its adoption rate due to shorter recovery times and fewer complications compared to traditional surgeries to treat cancer.

Latin America Tumor Ablation Market Analysis

Tumor ablation is a medical procedure that is utilized to destroy cancer cells in a tumor in various parts of the body, such as the liver, kidney, and bone. Some common tumor ablation approaches include radiofrequency ablation (RFA) and cryoablation. This technique can help in localized destruction of cancerous cells without the need for invasive surgery. Due to its minimally invasive nature, this technique is associated with shorter recovery times and fewer complications than traditional surgeries. Hence, the Latin America tumor ablation market demand is expected to witness a surge in the coming years.

Latin America has a significant burden of cancer which can be attributed to the rising aging populations, lifestyle changes, and genetic factors. Recent data reveals that 9 in 10 of the most populous nations in Latin America will observe at least a 64% increase in cancer patients by 2040. Further, it is estimated that nearly 1 million new cancer cases will occur in Brazil each year, which indicates the urgent need for effective cancer treatment options including tumor ablation techniques for managing different types of cancer. Consequently, the high cancer incidence is expected to drive the Latin America tumor ablation market growth.

The market is also influenced by the increased initiatives by both public and private organizations to tackle the growing cancer burden and spread awareness about its management strategies including advanced procedures like tumor ablation. For instance, in October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region. As a part of the World Code Against Cancer, the new Code will offer latest recommendations based on the most recent scientific evidence, influencing changes in health policies and behaviors to prevent cancer. Such initiatives are likely to heighten public awareness regarding the benefits of tumor ablation therapy and enhance its adoption rate, which is poised to augment the market share.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Latin America Tumor Ablation Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Latin America Tumor Ablation Market: Competitor Landscape

The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Medtronic

• Boston Scientific Corporation

• AngioDynamics

• Mermaid Medical

• HealthTronics

• Galil Medical Inc.

• EDAP TMS S.A.

• Misonix, Inc.

• NeuWave Medical, Inc.

• SonaCare Medical

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report